Targeting DNA Homologous Repair Proficiency With Concomitant Topoisomerase II and c-Abl Inhibition.

Siddiqui, Arafat; Tumiati, Manuela; Joko, Alia; Sandholm, Jouko; Roering, Pia; Aakko, Sofia; Vainionpää, Reetta; Kaipio, Katja; Huhtinen, Kaisa; Kauppi, Liisa; Tuomela, Johanna; Hietanen, Sakari

Siddiqui, Arafat; Tumiati, Manuela; Joko, Alia; Sandholm, Jouko; Roering, Pia; Aakko, Sofia; Vainionpää, Reetta; Kaipio, Katja; Huhtinen, Kaisa; Kauppi, Liisa; Tuomela, Johanna; Hietanen, Sakari.

Afiliação

Siddiqui A; Institute of Biomedicine, University of Turku, Turku, Finland.
Tumiati M; ONCOSYS, Research Programs Unit, University of Helsinki, Helsinki, Finland.
Joko A; Department of Biology, Åbo Akademi University, Turku, Finland.
Sandholm J; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.
Roering P; Institute of Biomedicine, University of Turku, Turku, Finland.
Aakko S; Institute of Biomedicine, University of Turku, Turku, Finland.
Vainionpää R; Laboratory of Genetics, HUS Diagnostic Center, Helsinki University Hospital, Helsinki, Finland.
Kaipio K; Institute of Biomedicine, University of Turku, Turku, Finland.
Huhtinen K; Institute of Biomedicine, University of Turku, Turku, Finland.
Kauppi L; ONCOSYS, Research Programs Unit, University of Helsinki, Helsinki, Finland.
Tuomela J; Institute of Biomedicine, University of Turku, Turku, Finland.
Hietanen S; Turku University Hospital, FICAN West Cancer Centre, Turku, Finland.

Front Oncol ; 11: 733700, 2021.

Article em En | MEDLINE | ID: mdl-34616682

Palavras-chave

DNA repair; c-Abl; cell cycle arrest; imatinib; mitoxantrone

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Finlândia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google